Perioperative medicine: what you need to know about new hypoglycemic medicines?
Периоперационная медицина: что необходимо знать о новых гипогликемических препаратах?
2026-07-24
SCID: 54.1/atxvfrxv
Discuss with AI
GIP receptor agonistsGLP-1 receptor agonistsSGLT2 inhibitorsgastric ultrasoundperioperative aspiration
Figures from the paper
Abstract (AI)
Rationale. In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and sodium-glucose cotransporter 2 inhibitors (SGLT2Is) have been increasingly used to treat diabetes mellitus, heart failure, and obesity. Their use is associated with the development of gastrostasis, which significantly increases the risk of perioperative aspiration and explains the increased attention anesthesiologists pay to this problem. Euglycemic or diabetic ketoacidosis may also develop. Methods. We searched PubMed, Web of Science, and eLibrary for the period 2016-2026 using the keywords "GLP-1 receptor agonists," "GLP-1 and GIP receptor agonists," "SGLT2Is," "anesthesia," "aspiration," and "regurgitation." Results. The programmed slowing of gastric motility caused by medications must be taken into account during anesthesia. A large body of clinical data has demonstrated that the medicines in question significantly increase the risk of aspiration and regurgitation. However, the timing of medicine withdrawal before anesthesia, the regimens for resuming treatment, and the conditions for emergency anesthesia remain unclear. Current international guidelines recommend varying timing of medicine withdrawal before anesthesia, recommend paying attention to characteristic dyspeptic symptoms, justify the need for gastric ultrasound if a large residual volume is suspected, and recommend a "full stomach" protocol during emergency interventions. Currently, there are no current guidelines for the perioperative care of such patients in the Russian Federation. Conclusion. The steady increase in the number of patients receiving new hypoglycemic agents requires an individualized approach to anesthesia, as well as the development of Russian clinical guidelines for the perioperative care of this patient population. Our proposed algorithm could form the basis for such guidelines, improving the safety of general anesthesia.
Key Findings
1
Clinical evidence indicates these medications significantly increase perioperative risks of gastric regurgitation and aspiration.
2
GLP-1, GIP, and SGLT2 inhibitors are increasingly used for diabetes, heart failure, and obesity, but may cause delayed gastric emptying relevant to anesthesia.
3
Individualized anesthetic management, gastric ultrasound when substantial residual volume is suspected, and Russian perioperative guidelines are needed; the proposed algorithm may improve general-anesthesia safety.
4
International guidelines vary on preoperative medication withdrawal and treatment resumption, while emergency procedures generally require a full-stomach protocol.
5
SGLT2 inhibitors and related therapies may be associated with euglycemic or diabetic ketoacidosis during the perioperative period.
Research Object
Patients receiving GLP-1 receptor agonists, GIP receptor agonists, or SGLT2 inhibitors undergoing anesthesia and perioperative care
Research Subject
Perioperative anesthesia risks and management, particularly medication-associated delayed gastric emptying, aspiration and regurgitation risk, ketoacidosis, medication withdrawal and resumption timing, and emergency anesthesia strategies
Publication Details
Publication Date
2026-07-24
Journal
Publisher
ISSN
Cited by
0
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia2024
ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists2023
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement2025
Emerging Anesthesia Risks with Semaglutide2023